Research > ETFs > ETF / ETP Commentary > 

Value ETFs: Less Dead Than Previously Believed

Once again, there has been plenty of discussion regarding the fate of value stocks and the related ETFs, including the SPDR Portfolio S&P 500 Value ETF (SPYV B+), this year.Several months ago, it appeared as though there was a legitimate rotation into value taking place, but as markets rebounded, some of value’s momentum waned. Or did it? SPYV is up 20% year-to-date and hit an all-time on Tuesday, prompting some market observers to say the value factor has not performed as poorly this year as some investors have been led to believe.SPYV’s underlying index “contains stocks that exhibit the strongest value characteristics based on: book value to price ratio; earnings to price ratio; and sales to price ratio,” according to State Street.There has been plenty of speculation regarding when value stocks will finally start outperforming growth names in earnest. Much of that chatter is attributable to growth’s lengthy out-performance of value. For nearly the entirety of the recent U.S. bull market, growth stocks and ETFs have bested their value rivals“To wit, the S&P 500 Value Index jumped Tuesday to an all-time high, bringing its total return since global markets bottomed in 2009 to over 400%,” according to Bloomberg. “That’s behind the 492% rally in its growth counterpart, made up of companies seen with potential for faster sales or profits. Still, for anyone who has stayed invested, the returns are hard to frame as awful.”Not Bad, Just Bad Against GrowthAs noted above, value’s problem and that of ETFs like SPYV hasn’t been a pure performance, but rather performance when measured against growth stocks and the related funds.However, it is not uncommon for value, or any factor for that matter, to under-perform for certain periods of time, but the length of value’s current laggard status is unusual.“Part of the grievance stems from value’s persistent underperformance since 2017. Over the stretch, recession fears erupted periodically, crimping investor appetite for risk. In their thinking, cheap stocks are cheap for a reason, and if the economy weakens, value stocks are at danger of becoming traps,” reports Bloomberg. “Growth is therefore favored, especially companies whose sales are perceived as resilient to economic cycles such as software makers.”Still, investors have been fond of some value ETFs in 2019. For example, SPYV has seen year-to-date inflows of $1.15 billion.This article originally appeared on ETFTrends.com.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.